Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal RUNX2 antibody. Carrier free. Suitable for ChIC/CUT&RUN-seq, IP, ChIP, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 10 publications.
View Alternative Names
AML3, CBFA1, OSF2, PEBP2A, RUNX2, Runt-related transcription factor 2, Acute myeloid leukemia 3 protein, Core-binding factor subunit alpha-1, Oncogene AML-3, Osteoblast-specific transcription factor 2, Polyomavirus enhancer-binding protein 2 alpha A subunit, SL3-3 enhancer factor 1 alpha A subunit, SL3/AKV core-binding factor alpha A subunit, CBF-alpha-1, OSF-2, PEA2-alpha A, PEBP2-alpha A
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (AB264077)
Immunohistochemical analysis of paraffin-embedded human osteosarcoma tissue labeling RUNX2 with ab236639 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on human osteosarcoma (PMID : 21731849) is observed. The section was incubated with ab236639 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
- IP
Unknown
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (AB264077)
RUNX2 was immunoprecipitated from 0.35 mg PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate 10ug with ab236639 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab236639 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 : ab236639 IP in PC-3 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab236639 in PC-3 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
All lanes:
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (<a href='/en-us/products/primary-antibodies/runx2-antibody-epr22858-106-chip-grade-ab236639'>ab236639</a>)
Predicted band size: 57 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (AB264077)
RUNX2 was immunoprecipitated from 0.35 mg Saos-2 (human osteosarcoma epithelial) whole cell lysate with ab236639 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab236639 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Saos-2 (human osteosarcoma epithelial) whole cell lysate 10ug
Lane 2 : ab236639 IP in Saos-2 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab236639 in Saos-2 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
All lanes:
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (<a href='/en-us/products/primary-antibodies/runx2-antibody-epr22858-106-chip-grade-ab236639'>ab236639</a>)
Predicted band size: 57 kDa
false
- ChIP
Unknown
ChIP - Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (AB264077)
Chromatin was prepared from Saos-2 cells according to the Abcam Dual-X-ChIP protocol*. Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min.
The ChIP was performed with 25 μg of chromatin, 5 μg of ab236639 (red), or 5 μg of rabbit normal IgG ab172730 (gray) and 20 μl of Protein A/G sepharose beads. The immunoprecipitated DNA was quantified by real time PCR (Taqman approach for active and inactive loci, Sybr green approach for heterochromatic loci).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (AB264077)
Immunohistochemical analysis of paraffin-embedded rat embryo 14.5 day tissue labeling RUNX2 with ab236639 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on the cartilage cells in the rat embryo 14.5 day tissue is observed. The section was incubated with ab236639 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (AB264077)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639). ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5X10^5 of positive cell line Saos-2 or low expression cell line HeLa were used along with 5µg of ab236639 [EPR22858-106]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Related conjugates and formulations (9)
-
Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade
-
660 APC
APC Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
578 PE
PE Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade
-
Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (Capture)
Reactivity data
Product details
ab264077 is the carrier-free version of ab236639.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein orchestrates bone formation by influencing the expression of genes involved in osteoblast differentiation. RUNX2 operates as part of the larger transcriptional complex that includes other proteins that modulate its activity. It maintains bone homeostasis by regulating the expression of osteogenic markers including bone sialoprotein and osteocalcin. The ability of RUNX2 to drive osteoblast lineage commitment highlights its importance in skeletal health and development.
Pathways
RUNX2 shows significant involvement in both the Wnt signaling and TGF-beta signaling pathways. Within the Wnt signaling pathway RUNX2 interacts with beta-catenin to facilitate osteoblastogenesis and support bone matrix deposition. In the TGF-beta signaling pathway RUNX2 modulates Smad-dependent transcriptional activity important for extracellular matrix production and bone remodeling. These interactions illustrate RUNX2's central role in mediating bone development and maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 22:540 PubMed39237942
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced biology 8:e2400341 PubMed39051421
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 30:57 PubMed38698308
2024
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 18:20230790 PubMed37711155
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genes & diseases 10:2097-2108 PubMed37492739
2023
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2023:6331650 PubMed36700172
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of applied oral science : revista FOB 30:e20220316 PubMed36417596
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 20:598-609 PubMed35846837
2022
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 12:338 PubMed34112236
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and applied biochemistry 67:1000-1010 PubMed31845407
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com